Floatz logo

Fludarabine

Peripheral T-cell Lymphomas (PTCL)

Huazhong University of Science and TechnologySmall moleculeEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

36 Active assets in the Peripheral T-cell Lymphomas (PTCL) cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Alliance for Clinical Trials in Oncology
Phase 4BB
Cyclophosphamide
City of Hope Medical Center
Phase 2BB
DEXAMETHASONE
Zhengzhou University
Phase 4BB
FILGRASTIM
City of Hope Medical Center
Phase 2BB
(+)-VINCRISTINE
City of Hope Medical Center
Phase 2BB

View all 50 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →